Public Debate:
Can we afford our medicines? The access to medicines crunch in Europe

12:30 – 3 p.m.
12 November, 2014

Room A3G-3, European Parliament
Brussels, Belgium

** Please see the Event Summary for this past event.

Although the European Union and its member states are committed to universal and equitable access to healthcare, millions of patients across Europe cannot afford many life-saving medicines. This debate will examine the current status quo regarding access to medicines in Europe and explore policy recommendations that could lead to more affordable medicines. Numerous potential solutions, including new forms of pooled procurement, price and data transparency, cost-therapeutic benefit assessment of medical products and greater generic competition, will be discussed. Biomedical R&D strategies that increase the social return of public investments and promote affordable health-driven innovation to ‘de-link’ research costs from final medicine prices will also be debated.

Registration is required and limited spaces are available. Please email your name, title and organisation to a2m.europe@gmail.com by 6 November, 2014. If you require a badge to access the European Parliament, please provide your full name, nationality, passport/ID number and date of birth.

If you are unable to attend, the debate will be livestreamed at http://greenmediabox.eu/en/live/can-we-afford-our-medicines.

(Light lunch)

Welcoming remarks by Kostas CHRYSOGONOS (GUE/NGL, EL)

Affordable access to medicines: the situation on the ground

Introduction by Beatriz BECERRA BASTERRECHEA (ALDE, ES) @beatrizbecerrab

Moderated by David Hammerstein @DaHammerstein, Senior policy advocate, TACD

  • François Berdougo @FBerdougo, Secretary General of the Harm Reduction Working Group of Médecins du Monde @MdM_France
  • Gonzalo Fanjul @GonzaloFanjul, Policy Director, IS Global Barcelona Institute for Global Health @ISGlobalorg
  • Rohit Malpani @MSF_access, Director, Access Campaign, Médecins Sans Frontières (MSF)

Q&A session

What can we do about the high cost of medicines?

Introduction by Michèle RIVASI (Greens/EFA, FR) @MicheleRivasi

Moderated by Ellen ‘t Hoen @ellenthoen, Medicines Law & Policy.

  • Jamie Love @jamie_love, Director, Knowledge Ecology International (KEI) & U.S. Chair of the Intellectual Property Committee, TACD
  • Teresa Alves, International Policy Adviser, La Revue Prescrire,
  • Prof. dr.  Graham Dukes, University of Oslo

Q&A session

Concluding remarks by Nessa CHILDERS (S&D, IE) @nchildersMEP

Please join the discussion on twitter using #a2mEurope. Also note that the event will be webstreamed live at http://greenmediabox.eu/en/live/can-we-afford-our-medicines

Organising Partners: TransAtlantic Consumer Dialogue, Salud por Derecho, Doctors of the World – Médecins du monde International Network, Universities Allied for Essential Medicines and Health Action International Europe

Supporting Members of the European Parliament: Nessa Childers (S&D, IE), Beatriz Becerra Basterrechea (ALDE, ES), Kostas Chrysogonos (GUE/NGL, EL), and Michèle Rivasi (Greens/EFA, FR).

Check out this event’s poster here!

HAI Europe Association Annual General Meeting

24 – 25 October, 2014

Amsterdam, The Netherlands

Raquel Wind at raquel@haiglobal.org

Health Projects for Latvia Summer School;
Understanding & Responding to Pharmaceutical Promotion

1-4 July 2014

Ventspils, Latvia


HAI Presentations:
Understanding & Responding to Pharmaceutical Promotion
Learning How Not to Do the Pharmaceutical Tango
Pharmaceutical Sales Representatives
Promotion, Professional Practice & Patient Trust